Harvard Bioscience

Harvard Bioscience Market capitalization

The The market capitalization of Harvard Bioscience (HBIO) as of Nov 22, 2026 is 24.80 M USD. In the previous year, The market capitalization was 24.80 M USD — a change of 0.00% (lower).

Market capitalization

24.80 MUSD

YoY

0.00%

Last updated:

In 2025, Harvard Bioscience's market cap stood at 24.80 M USD, a 0.00% increase from the 24.80 M USD market cap in the previous year.

The Harvard Bioscience Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
24.80 M USD
Jan 1, 2019
24.80 M USD
Jan 1, 2020
24.80 M USD
Jan 1, 2021
24.80 M USD
Jan 1, 2022
24.80 M USD
Jan 1, 2023
24.80 M USD
Jan 1, 2024
24.80 M USD
Jan 1, 2025
24.80 M USD
The Harvard Bioscience Market capitalization history
YEARMarket capitalizationYoY
24.80 MUSD0.00%
24.80 MUSD0.00%
24.80 MUSD0.00%
24.80 MUSD0.00%
24.80 MUSD0.00%
24.80 MUSD0.00%
24.80 MUSD0.00%
24.80 MUSD0.00%
24.80 MUSD0.00%
24.80 MUSD0.00%
24.80 MUSD0.00%
24.80 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Harvard Bioscience Stock analysis

What does Harvard Bioscience do? Harvard Bioscience Inc was founded in 1901 and is headquartered in Holliston, Massachusetts. The company is a global leader in providing instruments, technologies, and complete systems for science and research. Harvard Bioscience has established itself as one of the leading providers of products and solutions in the fields of life sciences and health research with over 100 years of industry experience. The business model of Harvard Bioscience is focused on delivering high-quality products and solutions for research needs. The company is divided into three business segments: Life Science Research Products, Preclinical Surgical Products, and Analytical Instruments. These business segments offer a variety of products, such as instruments for cell and molecular research, gene expression analysis devices, surgical instruments, and instruments for electrophysiology. The Life Science Research segment includes the business units Harvard Apparatus, Molecular Devices, and Denville Scientific. Harvard Apparatus provides instruments for cell and molecular research, physiological instruments, and animal model systems. Molecular Devices specializes in instrumental analysis methods for cell and molecular research. Denville Scientific is a leading supplier of products for cell and molecular biology, including materials for gene and protein expression and cell culture techniques. In the Preclinical Surgical Products segment, Harvard Bioscience operates with the company Hugo Sachs Elektronik. Surgical instruments and complete systems for preclinical research are offered here. These products are popular among scientists worldwide as they have been developed for conducting research with animal models. Analytical Instruments is the segment where the company operates joint ventures to develop instruments for physical, material, and life science research. In this segment, Harvard Bioscience is primarily involved in the joint venture Wasatch Microfluidics, alongside Agilent Technologies, which specializes in the development of instruments for life sciences and biotechnology. As a provider of science and research-related instruments and devices, Harvard Bioscience has a wide range of products to help researchers and scientists enhance their work more effectively. Some of the most popular products from Harvard Bioscience include tissue processing systems, neuroprotection applications, animal model holders, and electrophysiology platforms. Harvard Bioscience also offers a range of products for quality assurance and environmental protection, such as cleanroom and protection devices for material preparation and sterilization. Overall, Harvard Bioscience Inc has an excellent reputation in the industry and is one of the world's leading companies for scientific and research-related products and services. The company constantly strives to improve its products and services and adapts to the needs of its customers. It relies on innovation and continuously works to develop and implement new technologies to meet the demands of the scientific world. Harvard Bioscience is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Harvard Bioscience's Market Capitalization

Harvard Bioscience's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Harvard Bioscience's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Harvard Bioscience's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Harvard Bioscience’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Harvard Bioscience stock

The market capitalization of Harvard Bioscience is 24.80 M USD in 2025.

The market capitalization of Harvard Bioscience changed from 24.80 M USD to 24.80 M USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Harvard Bioscience since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Harvard Bioscience with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Harvard Bioscience

All Key Metrics — Harvard Bioscience